George Magrath - 09 Sep 2026 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: IRD
Reported as of: 09 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Sep 2026, 16:09:50 UTC
Prior SEC filing: 27 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy Rabourn, by Power of Attorney

Key filing fact

George Magrath filed Form 4 for Opus Genetics, Inc. (IRD) on 11 Sep 2026.

Key facts

This page summarizes George Magrath's Form 4 filing for Opus Genetics, Inc. (IRD).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Sep 2026, 16:09.

Change

Previous filing in this sequence was filed on 27 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001999390 Primary reporting owner

Magrath George

Relationship: Chief Executive Officer, Director
Address: C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM
Signature: /s/ Amy Rabourn, by Power of Attorney
Signature date: 11 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRD transaction

Common Stock

Options Exercise

Transaction value
Shares: +392,157
Change %: +23%
Price: $1.15^*
Shares after: 2,124,026
Date: 09 Sep 2026
Ownership: Direct

IRD transaction

Common Stock

Tax liability

Transaction value
Shares: -75,541
Change %: -3.6%
Price: $5.97^*
Shares after: 2,048,485
Date: 09 Sep 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRD transaction Derivative

Warrant (right to buy)

Options Exercise

Transaction value
Shares: -392,157
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 09 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 392,157
Exercise price: $1.15
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person paid the exercise price of the Warrant on a cashless basis. The Issuer withheld 75,541 shares, calculated in accordance with the terms of the Warrant, to pay the exercise price and issued the remaining 316,616 shares to the Reporting Person.

Footnote F2

The Warrant was immediately exercisable upon its acquisition on March 24, 2025, subject to the Issuer's right to call the Warrant at any time beginning 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's Common Stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day.